Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2025-12-27 @ 11:12 PM
Study NCT ID:
NCT04314934
Status:
COMPLETED
Last Update Posted:
2024-08-12
First Post:
2019-12-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
OLE of Phase 2b/3 Study ANAVEX2-73-AD-004
Sponsor:
Anavex Life Sciences Corp.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10-10
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-14
Completion Date Type:
ACTUAL
First Submit Date:
2019-12-12
First Submit QC Date:
None
Study First Post Date:
2020-03-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-09
Last Update Post Date:
2024-08-12
Last Update Post Date Type:
ACTUAL